medigraphic.com
ISSN 1561-302X (Impreso)

2014, Número 1

<< Anterior Siguiente >>

Rev cubana med 2014; 53 (1)


Perspectiva clínica de los trastornos de la glucemia en pacientes hospitalizados

Buchaca FEF, Fernández VF, Rodríguez AL, Bermúdez RS

Idioma: Español
Referencias bibliográficas: 59
Paginas: 61-75
Archivo PDF: 94.65 Kb.


RESUMEN

La hiperglucemia asociada a la hospitalización es un fenómeno frecuente en la práctica clínica y ha cobrado una relevancia particular como biomarcador pronóstico de la evolución clínica de los sujetos ingresados por diferentes causas. Los pacientes con diabetes mellitus constituyen un grupo de riesgo particular que presentan frecuentemente situaciones agudas y requieren de servicios asistenciales en instituciones de salud. En esta revisión se actualizan los criterios de diagnóstico de los diferentes trastornos de la glucemia y se exponen los principales mecanismos patogénicos y fisiopatológicos que determinan su desencadenamiento, así como su probable asociación con complicaciones médicas. Se exponen metas de control de la glucemia para diferentes situaciones clínicas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-21.

  2. República de Cuba. Ministerio de Salud Pública. Anuario estadístico 2012. Prevalencia de diabetes mellitus, hipertensión arterial y asma bronquial según provincia. P. 97.

  3. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep. 2009;57:1-134.

  4. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421-6.

  5. Tschöpe D, Hanefeld M, Meier JJ, Gitt AK, Halle M, Bramlage P, et al. The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovasc Diabetol. 2013;12(1):62.

  6. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-82.

  7. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355:1903-11.

  8. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421-6.

  9. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353-69.

  10. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetesusing self-monitoring blood glucose and hemoglobin A1c. JAMA. 2006;295:1688-97.

  11. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97:163-8.

  12. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-91.

  13. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35:2262-67.

  14. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32:1153-57.

  15. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94:709-28.

  16. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991;260:E67-E74.

  17. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. 2013;36:1384-95.

  18. Nishikawa T, Edelstein D, Du XL. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-90.

  19. Tan KC, Chow WS, Ai VH. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care. 2002;25:1055-9.

  20. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infartion in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.

  21. Leonidou L, Mouzaki A, Michalaki M, De Lastic AL, Kyriazopoulou V, Bassaris HP, et al. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007;55:340-6.

  22. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906-12.

  23. García García Y, Licea Puig ME, Garciga Cardoso F, Álvarez Delgado Y, Barnés Domínguez JA, Almaguer García S, et al. Control glucémico en el proceso perioperatorio de los pacientes con diabetes mellitus. Rev Cubana Endocrinol [revista en la Internet]. 2012 Abr [citado 27 Ago 2013]; 23(1): 62-75. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532012000100006&lng=es

  24. Anderson RE, Tan WK, Mertin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state and infarction in the ischaemic penumbra. Stroke. 1999;30:160-70.

  25. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care. 2007;30:367-69.

  26. Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med. 2007;2:234-40.

  27. Tsujimoto T, Yamamoto-Honda R, Kajio H. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care. 2013; DOI: 10.2337/dc13-0701. Disponible en: http://care.diabetesjournals.org

  28. Vilar-Compte D, Alvarez de Iturbe I, Martín-Onraet A, Pérez-Amador M, Sánchez-Hernández C, Volkow P. Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy. Am J Infect Control. 2008;36(3):192-8.

  29. Mc Alister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2 471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810-15.

  30. Kadoi Y. Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus. J Anesth. 2010;24:739-47.

  31. Stranders I, Diaman M, Van Gelde RE, Spruijt HWR, Twisk J, Heine R, et al. Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes Mellitus. Arch Intern Med. 2004;164(9):982-8.

  32. Sinnaeve P, Steg P, Fox K, Van de Werf F, Montalescot G, Granger C, et al. for the GRACE Investigators. Association of Elevated Fasting Glucose with Increased Short-term and 6-Month Mortality in ST-Segment Elevation and Non-ST-Segment Elevation Acute Coronary Syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med. 2009;169(4):402-9.

  33. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27(11):1289-97.

  34. Yong M, Kaste M. Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II Trial. Stroke. 2008;39:2749-55.

  35. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycaemia and prognosis of stroke in nondiabetic and diabetic patients. A systematic overview. Stroke. 2001;32:2426-32.

  36. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD; On Behalf Of The Canadian Alteplase For Stroke Effectiveness Study (CASES) Investigators. Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis. Diabetes Care. 2009;32:617-22.

  37. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, et al. Association between elevated blood glucose and outcome in Acute Heart Failure. Results from an International Observational Cohort. J Am Coll Cardiol. 2013;61(8):820-9.

  38. Mc Allister F, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The Relation Between Hyperglycemia and Outcomes in 2,471 Patients Admitted to the Hospital With Community-Acquired Pneumonia. Diabetes Care. 2005;28:810-5.

  39. Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery. Diabetes Care. 2010;33:1783-8.

  40. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389-94.

  41. Anthony M. Treatment of hypoglycemia in hospitalized adults: a descriptive study. Diabetes Educ. 2007;33:709-15.

  42. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364-79.

  43. Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013;347:f4533.

  44. Bonds DE, Miller ME, Bergenstal RM. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909.

  45. The NICE-SUGAR Study Investigators. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med. 2009;360(13):1283-97.

  46. Boucai L, Southern W, Zonszein J. Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to Comorbidities. Am J Med. 2011;124:1028-35.

  47. Rendell M, Saiprasad S, Alejandro G, Carrasco T, Drincic A. The Future of In-Patient Diabetes Management: Glucose as the Sixth Vital Sign. Expert Rev Endocrinology and Metabolism-Medscape. 2013.

  48. Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV. New-generation diabetes management: glucose sensor-augmented insulin pump therapy. Expert Rev Med Devices. 2011;8(4):449-58.

  49. Seley JJ, D'hondt N, Longo R, Manchester C, McKnight K, Olson L, et al. AADE position statement: inpatient glycemic control. TDE. 2009;35(Suppl 3):64S-68S.

  50. Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33:467-72.

  51. Fernández Concepción O, Buergo Zuaznábar MA, López Jiménez M. Hiperglicemia post-ictus. Rev Cubana Neurol Neurocir. 2012;2(2):144-9.

  52. Sinclair A, Morley JE, Rodríguez-Mañas L, Paolisso G, Bayer T, Zeyfang A, et al. Diabetes Mellitus in Older People: Position Statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAMDA. 2012;13:497-502.

  53. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in Older Adults. Diabetes Care. 2012;35:2650-64.

  54. Sharabash HM, Remington TL, Mar P, Winston R, Walker PC. Retrospective review of metformin in inpatients and outpatients at the University of Michigan. Diabetes Care. 2006;29:170-1.

  55. Adams HP, Del Zoppa G, Alberts MJ. For the American Heart Association, American Stroke Association Stroke Council. Guidelines for the early management of adults with ischaemic stroke. Stroke. 2007;38:1655-711.

  56. The European Stroke Organization (ESO) Executive Committee and ESO Writing Committee: Guidelines for the Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis. 2008;25:457-507.

  57. Qaseem A, Chou R, Humphrey L, Shekelle P. Inpatient Glycemic Control: Best Practice Advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Quality. 2013;XX(X):1-4.

  58. Hirsch IB. Sliding Scale Insulin-Time to Stop Sliding. JAMA. 2009;301(2):213-4.

  59. Marks JB. Perioperative Management of Diabetes. Am Fam Physician. 2003;67(1):93-100.




2020     |     www.medigraphic.com